{
  "id": "f61c1a363096fa0a",
  "title": "STAT+: Novartis\u2019 biomedical research head on AI, pruning the pipeline, and a potential blockbuster",
  "description": "The head of biomedical research at Novartis spoke with STAT about AI, pruning the pipeline, and a potential blockbuster.",
  "content": "The head of biomedical research at Novartis spoke with STAT about AI, pruning the pipeline, and a potential blockbuster.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/02/11/inside-novartis-research-development-big-bets-gene-therapy-ai/?utm_campaign=rss",
  "published_at": "2026-02-11T09:30:00+00:00",
  "fetched_at": "2026-02-12T00:28:38.246764+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Novartis\u2019 biomedical research head on AI, pruning the pipeline, and a potential blockbuster",
    "description": "The head of biomedical research at Novartis spoke with STAT about AI, pruning the pipeline, and a potential blockbuster.",
    "url": "https://www.statnews.com/2026/02/11/inside-novartis-research-development-big-bets-gene-therapy-ai/?utm_campaign=rss",
    "published": "2026-02-11T09:30:00+00:00",
    "source": "STAT"
  }
}